Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Kyttaro logo

ABOUT THE ROLE

Kyttaro seeks an outstanding, highly driven and top-performing Associate Scientist / Scientist with experience in cellular biology to support Kyttaro’s anti-inflammatory drug discovery platform technology program.

 

The successful candidate will:

1) lead development and validation of cell-based functional assays to advance the development of our technology platform using various applications including but not limited to flow cytometry, western blot, ELISA and immunoprecipitation;

2) work closely with chemist, molecular, structural, and computational biologists, as well as immunologists, medicinal chemists and biochemical researchers in a multidisciplinary environment to characterize compounds with therapeutic and diagnostic application in inflammatory disease;

3) be able to confidently lead his/her areas of responsibility as well as interface with the broader team, communicating results across disciplines.

The successful candidate will have the opportunity to interact and work with leading scientists and business leaders from premier institutions and to help translate emerging therapeutic ideas into reality.

 

RESPONSIBILITIES:

  • Support building up a cellular biology lab for cell-based functional assays
  • Lead the cellular biology work to support the development of our technology platform
  • Design and execute cellular assays to screen peptides using flow cytometry, ELISA-based techniques, western blotting, immunoprecipitation and reporter assays
  • Identify and develop suitable techniques / experimental protocols for cell-based assays in collaboration with other team members
  • Meticulously conduct experiments and analyse and interpret the data
  • Manages project from initiation to launch, while balancing multiple project assignments
  • Maintain accurate experimental records
  • Collaborate closely with academic partners and/or contract research organisations
  • Write reports and present findings to colleagues

 

ESSENTIAL QUALIFICATIONS / SKILLS:

  • PhD with a strong background in cellular biology and molecular biology
  • Mature and broad skills in cell-based and biochemical assays such as flow cytometry, ELISA, western blotting, immunoprecipitation, enzyme assay and/or reporter gene assays
  • Experience in mammalian cell culture, peripheral blood, and/or buffy coat cell extraction and handling
  • Ability to independently design, execute and interpret scientific experiments
  • Excellent communication and presentation skills
  • Possess flexibility and excitement for new challenges
  • Ability to work in a fast-paced environment, balancing multiple projects

 

DESIRABLE QUALIFICATIONS / SKILLS:

  • PhD in biology, life sciences or a relevant field with +2 years of industry experience is preferred
  • Experience in chemokines, cytokines, cell migration assay, nanoparticle modification and/or fluorescence polarization assay is preferred
  • Experience in inflammatory and/or cardiovascular disease is preferred

Job Types: Full-time, Permanent

Salary: From £50,000.00 per year

Schedule:

  • Day shift

Education:

  • PhD (required)

Work remotely:

  • No

 

ABOUT KYTTARO

Kyttaro is a UK-based clinical-stage bioscience company focused on developing first-in-class biologic therapeutics treating inflammatory, metabolic, gastrointestinal, and cardiovascular diseases to improve global health and patients’ lives. Kyttaro’s lab is located at the BioEscalator – a world-class launching pad for biotech companies that commercialize technology developed by Oxford University.

Kyttaro is an affiliate of Cambridge Science (CSC), a Boston-based bioscience company with a successful track record of launching and co-founding companies with some of the world’s top Principal Investigators. Apart from Kyttaro, CSC has already launched two emerging life science companies, Vivtex and Ovibio, and will continue to evolve into a diversified biotech company running multiple research and development, clinical, and commercial programs. Through pursuing the venture creation business model, CSC has been able to leverage its top-tier science and network across scientific programs to create a unique value proposition for its shareholders and, ultimately, patients.